TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 02, 1983Vol.9 No.46
TCL Archive Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now December 02, 1983Vol.9 No.46
TCL Archive Cooperative Group Chairman Unhappy Over Exclusion From Funding at Recommended Levels December 02, 1983Vol.9 No.46
TCL Archive Workshop Calls For Improved Surgical Oncology Training Programs December 02, 1983Vol.9 No.46
TCL Archive Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55 November 25, 1983Vol.9 No.45
TCL Archive In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew November 25, 1983Vol.9 No.45
TCL Archive DRCCA Staff Boom To 145, Still Growing, Still Looking for People November 25, 1983Vol.9 No.45
